Landsend Erlend S, Utheim Øygunn A, Pedersen Hilde R, Lagali Neil, Baraas Rigmor C, Utheim Tor P
Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Surv Ophthalmol. 2018 Jan-Feb;63(1):105-113. doi: 10.1016/j.survophthal.2017.09.004. Epub 2017 Sep 18.
Congenital aniridia is a rare panocular disease caused by fundamental disturbances in the development of the eye, characterized primarily by hypoplasia of the iris and macula. Severe secondary complications such as keratopathy, cataract, and glaucoma are common and often lead to considerable visual impairment or blindness. Many complications in aniridia patients are difficult to treat and present a challenge for the ophthalmologist. Increasingly, associated nonocular features of the disease are also being recognized. Over the past decades, major steps have been made in the understanding of the genetic basis of aniridia. Moreover, recent studies have prepared the ground for future treatment options based on specific mutations. Therefore, specific knowledge about genetics in aniridia has become more important than ever. We provide an overview of the field of aniridia genetics and its clinical implications.
先天性无虹膜是一种罕见的全眼球疾病,由眼部发育的根本性紊乱引起,主要特征为虹膜和黄斑发育不全。严重的继发性并发症如角膜病变、白内障和青光眼很常见,常导致严重的视力损害或失明。无虹膜患者的许多并发症难以治疗,给眼科医生带来挑战。越来越多的该疾病相关非眼部特征也得到了认识。在过去几十年里,对无虹膜遗传基础的理解取得了重大进展。此外,最近的研究为基于特定突变的未来治疗选择奠定了基础。因此,关于无虹膜遗传学的具体知识比以往任何时候都更加重要。我们概述了无虹膜遗传学领域及其临床意义。